With the onset of the 21st century marked by a staggering growth in artificial intelligence (AI) capabilities, we have witnessed groundbreaking advancements and transformations across various industries.
Researchers at NYU Langone Health's Perlmutter Cancer Center and the University of Glasgow developed and tested the program. They say that because it incorporates structural features of tumors from 452 adenocarcinoma patients,
The discoveries, detailed in the June 11 online issue of Nature Genetics, reveal genetic factors impacting heart disease that open new avenues for targeted treatments and personalized approaches to cardiovascular care.
Bayer AG today announced a strategic collaboration with Samsung Electronics America, Inc. to address data gaps on sleep disturbances associated with menopause (SDM). The companies will co-develop an observational study to further improve the understanding of the burden and impact of SDM using data provided by women through Samsung consumer devices.
Like many conditions, epilepsy treatment starts with early detection.
Mammography successfully reduces breast cancer mortality, but also carries the risk of false-positive findings. In recent years, researchers have studied the use of AI systems in screening.
Using machine learning techniques developed at the AI for Health Institute at Washington University in St. Louis, Chenyang Lu, the Fullgraf Professor in the university's McKelvey School of Engineering, collaborated with Jacob Greenberg, MD, assistant professor of neurosurgery at the School of Medicine, to develop a way to predict recovery more accurately from lumbar spine surgery.